BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23867303)

  • 1. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.
    Liu Y; Sattarzadeh A; Diepstra A; Visser L; van den Berg A
    Semin Cancer Biol; 2014 Feb; 24():15-22. PubMed ID: 23867303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance.
    Aldinucci D; Celegato M; Casagrande N
    Cancer Lett; 2016 Sep; 380(1):243-52. PubMed ID: 26474544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
    Chiu J; Ernst DM; Keating A
    Front Immunol; 2018; 9():267. PubMed ID: 29491867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction.
    Tudor CS; Distel LV; Eckhardt J; Hartmann A; Niedobitek G; Buettner M
    Hum Pathol; 2013 Nov; 44(11):2475-86. PubMed ID: 24029709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells.
    Alvaro T; Lejeune M; García JF; Salvadó MT; López C; Bosch R; Jaén J; Escrivá P; Pons LE
    Clin Cancer Res; 2008 Feb; 14(3):685-91. PubMed ID: 18245527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma.
    Wein F; Weniger MA; Höing B; Arnolds J; Hüttmann A; Hansmann ML; Hartmann S; Küppers R
    Cancer Immunol Res; 2017 Dec; 5(12):1122-1132. PubMed ID: 29070649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
    Aldinucci D; Gloghini A; Pinto A; De Filippi R; Carbone A
    J Pathol; 2010 Jul; 221(3):248-63. PubMed ID: 20527019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
    Kelley TW; Pohlman B; Elson P; Hsi ED
    Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment.
    Ferrarini I; Rigo A; Zamò A; Vinante F
    Leuk Lymphoma; 2019 Dec; 60(14):3395-3405. PubMed ID: 31304817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the microenvironment in human immunodeficiency virus-associated classical Hodgkin lymphoma.
    Koulis A; Trivedi P; Ibrahim H; Bower M; Naresh KN
    Histopathology; 2014 Dec; 65(6):749-56. PubMed ID: 24809535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It.
    Aldinucci D; Borghese C; Casagrande N
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T cells in the microenvironment of Hodgkin lymphoma.
    Wein F; Küppers R
    J Leukoc Biol; 2016 Jan; 99(1):45-50. PubMed ID: 26320264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.
    Vardhana S; Younes A
    Haematologica; 2016 Jul; 101(7):794-802. PubMed ID: 27365459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
    Yurchenko M; Sidorenko SP
    Exp Oncol; 2010 Dec; 32(4):214-23. PubMed ID: 21270747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cells and immune microenvironment in malignant lymphoma.
    de Jong D; Enblad G
    J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma.
    Calabretta E; d'Amore F; Carlo-Stella C
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy.
    Montanari F; Diefenbach CS
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):518-24. PubMed ID: 26351815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.
    Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; de Nully Brown P; Enblad G; Amini RM; Hjalgrim H; Glimelius I
    Eur J Haematol; 2018 Jan; 100(1):88-97. PubMed ID: 29064587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
    Liu WR; Shipp MA
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):310-316. PubMed ID: 29222272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.